ProPublica

Journalism in the Public Interest

Cancel

Prescriber Checkup

At A Glance: This Prescriber in 2012

General Practice

Self-Reported Primary Specialty

See Other Prescribers With This Specialty in This State »

9,979Medicare Part D Prescriptions Filled, Including Refills

Rank: 9 out of 139

$629K Total Retail Price of All Prescriptions

Rank: 8 out of 139

334 Patients Receiving at Least One Drug in Part D
51%Patients 65 Years and Older
79% Subsidized Claims for Low-Income Patients

How Does This Prescriber Compare to Peers?

In the same specialty and state. Caveats »

Drugs That Present Special Risks
Costs of Prescribing
Higher avg Average for
this specialty
in Michigan
Lower avg

Schedule Two
Controlled Substances

15% of this provider’s 334 patients filled at least one prescription for a schedule two drug, compared to an average of 8%.

Schedule Three
Controlled Substances

52% of this provider’s 334 patients filled at least one prescription for a schedule three drug, compared to an average of 29%.

Risky Drugs to Seniors

3% of this provider’s 4,458 prescriptions for patients 65 and older were for "potentially dangerous" drugs, compared to an average of 2%.

Brand Name Drugs

25% of this provider’s prescriptions were for brand-name drugs, compared to an average of 22%.

Prescription Price

$63 was the average price of a prescription from this provider, compared to $57 among peers.

Prescriptions per Patient

30 is the average number of prescriptions (including refills) per patient, compared to an average of 20.


Another View

This chart shows a different comparison of all providers in this specialty based on their mix of drugs and volume. Providers are grouped by similarity; those least like their peers are farthest to the right. Hover over the bars to see names of other prescribers.

← Prescribers more like their peers Prescribers less like their peers →
KEY: How to read this
chart

Fewer Prescribers
More Prescribers

This Prescriber
Hover to see more prescribers

This Prescriber's Drugs

The table below list this provider’s drugs, the number of prescriptions and how many went to seniors. Drugs are ranked by volume and compared with the rank for all providers in the same specialty and state.

Click to Filter by Category

Clear Filter


S2

A schedule two drug. More » Schedule two drugs have a high potential for abuse and severe dependence, according to the Drug Enforcement Administration.

S3

A schedule three drug. More » Schedule three drugs have potential for abuse and dependence, according to the Drug Enforcement Administration.

A

An antipsychotic drug. More » Antipsychotics are frequently given to dementia patients, though it increases their risk of death.

R

A risky drug for seniors. More » The American Geriatrics Society has said this drug is "potentially dangerous" for seniors and might be inappropriate.

10

This provider is among the top 10 prescribers of
this drug in the country.

This provider’s prescriptions for this drug were for more days than those of peers. More » Because of this, his or her prescription count may be lower.

This provider’s prescriptions for this drug were for fewer days than those of peers. More » Because of this, his or her prescription count may be higher.

This Drug's Rank
Drug Name Total Prescriptions Filled
Including Refills
Prescriptions
to 65+
Category For this Prescriber For All Prescribers in
This Specialty in Michigan
HYDROCODONE-ACETAMINOPHEN 1,440 532 S3 1 1
LEVOTHYROXINE SODIUM 531 323 2 6
SIMVASTATIN 335 170 3 3
FUROSEMIDE 253 143 4 7
OMEPRAZOLE 234 76 5 5
LISINOPRIL 194 97 6 2
METFORMIN HCL 185 107 7 8
ZOLPIDEM TARTRATE 153 97 8 27
CYCLOBENZAPRINE HCL 148 32 R 9 39
CIPROFLOXACIN HCL 145 55 10 53
OXYCODONE HCL-ACETAMINOPHEN 142 23 S2 11 95
DOXYCYCLINE HYCLATE 136 65 12 124
POTASSIUM CHLORIDE 133 79 13 12
LISINOPRIL-HYDROCHLOROTHIAZIDE 132 71 14 25
GABAPENTIN 119 27 15 13
PROAIR HFA 113 20 16 10
ATENOLOL 107 75 17 18
CARISOPRODOL 106 26 R 18 14
CYMBALTA 100 36 19 57
MORPHINE SULFATE ER 100 0 S2 19 69
SERTRALINE HCL 99 23 21 29
TRAMADOL HCL 96 45 22 19
LOSARTAN-HYDROCHLOROTHIAZIDE 91 55 23 93
TRAZODONE HCL 86 37 24 56
RANITIDINE HCL 85 42 25 15
ZETIA 83 34 26 108
FLUOXETINE HCL 83 17 26 84
HYDROCHLOROTHIAZIDE 81 58 28 11
MORPHINE SULFATE 76 0 S2 29 114
CLOPIDOGREL 68 49 30 37
PLAVIX 68 45 30 52
AZITHROMYCIN 66 43 32 40
SPIRIVA 64 60 33 45
DIPHENOXYLATE-ATROPINE 64 29 33 243
ADVAIR DISKUS 63 37 35 24
DIOVAN HCT 62 28 36 248
CARVEDILOL 60 21 37 22
ALLOPURINOL 58 58 38 51
LOSARTAN POTASSIUM 54 25 39 36
OXYCODONE HCL 54 0 S2 39 17
DICYCLOMINE HCL 54 31 39 268
TRIAMCINOLONE ACETONIDE 54 31 39 116
LANTUS SOLOSTAR 53 40 43 94
HYDROMORPHONE HCL 53 16 S2 43 182
BUMETANIDE 50 29 45 62
About This Data

ProPublica obtained prescribing data from Medicare’s prescription drug benefit, known as Part D, under the Freedom of Information Act. The data for 2012 includes more than 1.2 billion prescriptions written by nearly 1.5 million doctors, nurses and other providers. This database lists about 382,000 of those providers who wrote 50 or more prescriptions for at least one drug that year. Almost three-fourths went to patients 65 and older; the rest were for disabled patients. Methodology »

Incorrect Info?

If you are a provider and you believe your address is incorrect, check the listing you created on the National Provider Identifier registry. If you change your listing, send a note to drugs@propublica.org and we will update your information. If you have other questions about this data, send a note to drugs@propublica.org.

Caveats
  • No comparisons are shown if 10 or fewer prescribers in the state share this specialty.
  • The list of top drugs includes only those for which this provider wrote 50 or more prescriptions, but all prescriptions are counted in the summary totals at the top.
  • The calculation of “Risky Drugs to Seniors” does not include drugs for which a provider wrote 11 or fewer prescriptions because Medicare redacted the information to protect patient privacy.
  • Comparisons do not take into account the medical conditions of patients. Medications for certain conditions do not have generic alternatives, so patients would receive more expensive brand name drugs.
  • This provider's address and specialty information was last updated on July 15, 2010.
  • Comparisons are based on each provider’s current address, not necessarily where he or she worked during the time period covered in this database.